Capital Expenditures for Bristol-Myers Squibb (BMY)
According to Bristol-Myers Squibb's latest reported financial statements, the company's current capital expenditures (TTM) is $1.31B USD. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingCapital ExpendituresSwitch metric
Latest period
$1.31B
YoY change
+5.0%
5Y CAGR
+11.7%
Peak year (2025)
$1.31B
Cumulative capital expenditures
$29.42B
CapEx history chart for Bristol-Myers Squibb (BMY) from 1989 to 2025
CapEx history table for Bristol-Myers Squibb (BMY) from 1989 to 2025
| Fiscal year | Period ended | Reported | Capital Expenditures | YoY |
|---|---|---|---|---|
| 2025 | $1.31B | +5.0% | ||
| 2024 | $1.25B | +3.2% | ||
| 2023 | $1.21B | +8.1% | ||
| 2022 | $1.12B | +14.9% | ||
| 2021 | $973.00M | +29.2% | ||
| 2020 | $753.00M | -9.9% | ||
| 2019 | $836.00M | -12.1% | ||
| 2018 | $951.00M | -9.9% | ||
| 2017 | $1.05B | -13.2% | ||
| 2016 | $1.22B | +48.2% | ||
| 2015 | $820.00M | +55.9% | ||
| 2014 | $526.00M | -2.0% | ||
| 2013 | $537.00M | -2.0% | ||
| 2012 | $548.00M | +49.3% | ||
| 2011 | $367.00M | -13.4% | ||
| 2010 | $424.00M | -41.9% | ||
| 2009 | $730.00M | -22.4% | ||
| 2008 | $941.00M | +11.6% | ||
| 2007 | $843.00M | +6.3% | ||
| 2006 | $793.00M | +3.3% | ||
| 2005 | $768.00M | -5.1% | ||
| 2004 | $809.00M | -18.3% | ||
| 2003 | $990.00M | -16.2% | ||
| 2002 | $1.18B | +15.5% | ||
| 2001 | $1.02B | +73.7% | ||
| 2000 | $589.00M | -16.9% | ||
| 1999 | $709.00M | -10.0% | ||
| 1998 | $788.00M | +2.7% | ||
| 1997 | $767.00M | +27.6% | ||
| 1996 | $601.00M | +17.2% | ||
| 1995 | $513.00M | -10.5% | ||
| 1994 | $573.00M | +0.5% | ||
| 1993 | $570.00M | -11.9% | ||
| 1992 | $647.00M | +3.0% | ||
| 1991 | $628.00M | +22.4% | ||
| 1990 | $513.00M | -7.6% | ||
| 1989 | $555.00M | — |
CapEx values are taken from Bristol-Myers Squibb's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Bristol-Myers Squibb (BMY) capital expenditures totalled $1.31B – grew 5.0% year-over-year.
Bristol-Myers Squibb capital expenditures compound annual growth for the 2020–2025 (5 years) window is +11.7%, sustaining 5 straight years of year-over-year growth.
Across the available history, capital expenditures reached its high of $1.31B in 2025 and its low of $367.00M in 2011.
Bristol-Myers Squibb (BMY) sits 8th of 8 Healthcare peers we track on this metric, against a peer median of $3.87B.
Bristol-Myers Squibb Capital Expenditures by Year
Bristol-Myers Squibb Capital Expenditures 2025: $1.31B
Bristol-Myers Squibb capital expenditures in 2025 was $1.31B, grew 5.0% from 2024. This figure represents the highest annual value in the available history.
Bristol-Myers Squibb Capital Expenditures 2024: $1.25B
Bristol-Myers Squibb capital expenditures in 2024 was $1.25B, edged up 3.2% from 2023.
Bristol-Myers Squibb Capital Expenditures 2023: $1.21B
Bristol-Myers Squibb capital expenditures in 2023 was $1.21B, grew 8.1% from 2022.
Bristol-Myers Squibb Capital Expenditures 2022: $1.12B
Bristol-Myers Squibb capital expenditures in 2022 was $1.12B, grew 14.9% from 2021.
Bristol-Myers Squibb Capital Expenditures 2021: $973.00M
Bristol-Myers Squibb capital expenditures in 2021 was $973.00M.
See more financial history for Bristol-Myers Squibb (BMY).
Sector peers — CapEx
Companies in the same sector as Bristol-Myers Squibb, ranked by their latest capital expenditures.
| Company | Capital Expenditures | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $90.11B | Healthcare |
| Eli Lilly and Company (LLY) | $7.84B | Healthcare |
| Johnson & Johnson (JNJ) | $4.83B | Healthcare |
| Merck & Co., Inc. (MRK) | $4.11B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $3.62B | Healthcare |
| AstraZeneca PLC (AZN) | $2.81B | Healthcare |
| Amgen Inc. (AMGN) | $1.86B | Healthcare |
| AbbVie Inc. (ABBV) | $1.21B | Healthcare |
Frequently asked questions
What is Bristol-Myers Squibb's capital expenditures?
- Latest reported capital expenditures for Bristol-Myers Squibb (BMY) is $1.31B (period ending December 31, 2025).
How has Bristol-Myers Squibb capital expenditures changed year-over-year?
- Bristol-Myers Squibb (BMY) capital expenditures changed +5.0% year-over-year on the latest annual filing.
What is the long-term growth rate of Bristol-Myers Squibb capital expenditures?
- Bristol-Myers Squibb (BMY) capital expenditures compound annual growth rate is +11.7% over the most recent 5 years available.
When did Bristol-Myers Squibb capital expenditures hit its highest annual value?
- Bristol-Myers Squibb capital expenditures reached its highest annual value of $1.31B in 2025.
What was Bristol-Myers Squibb capital expenditures in 2024?
- Bristol-Myers Squibb (BMY) capital expenditures in 2024 was $1.25B.
What was Bristol-Myers Squibb capital expenditures in 2025?
- Bristol-Myers Squibb (BMY) capital expenditures in 2025 was $1.31B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
BMY Overview
Company profile, financial tools, and key metrics
BMY Revenue Counter
Earns $1,528 every second. See per minute, hour, and day.
BMY Earnings Counter
Earns $223.65 per second net profit. See per minute, hour, and day.
BMY Economic Scale
Exceeds Bahrain's GDP. Compare with world economies.
BMY What If Invested
What if you had invested $1,000? See historical returns from any date.
BMY How It Makes Money
Discover visual breakdown of $48.19B in revenue — where it comes from and where it goes.
BMY Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
BMY Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
BMY Daily Price Character
Steady · 47.3% historical win rate (green days). Streaks & record days.
BMY Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
BMY Stock Split History
6 splits on record. Dates, ratios, and cumulative multiple.
BMY Dividend Profile
Yield: 4.34%. Safety: 7/8. See full history.
BMY Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
BMY Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.